key: cord-0703100-9dqeeb0f
authors: Reiss, Karina; Leitzke, Sinje; Seidel, Jana; Sperrhacke, Maria; Bhakdi, Sucharit
title: Scramblases as Regulators of Proteolytic ADAM Function
date: 2022-02-04
journal: Membranes (Basel)
DOI: 10.3390/membranes12020185
sha: 0c7d7d36670ba8676cce0249e108e77edafb4889
doc_id: 703100
cord_uid: 9dqeeb0f

Proteolytic ectodomain release is a key mechanism for regulating the function of many cell surface proteins. The sheddases ADAM10 and ADAM17 are the best-characterized members of the family of transmembrane disintegrin-like metalloproteinase. Constitutive proteolytic activities are low but can be abruptly upregulated via inside-out signaling triggered by diverse activating events. Emerging evidence indicates that the plasma membrane itself must be assigned a dominant role in upregulation of sheddase function. Data are discussed that tentatively identify phospholipid scramblases as central players during these events. We propose that scramblase-dependent externalization of the negatively charged phospholipid phosphatidylserine (PS) plays an important role in the final activation step of ADAM10 and ADAM17. In this manuscript, we summarize the current knowledge on the interplay of cell membrane changes, PS exposure, and proteolytic activity of transmembrane proteases as well as the potential consequences in the context of immune response, infection, and cancer. The novel concept that scramblases regulate the action of ADAM-proteases may be extendable to other functional proteins that act at the cell surface.

Membrane anchored metalloproteases of the ADAM family assume central functions in the living cell by the controlled cleavage and release of biologically active proteins and peptides from the membrane surface. Two predominant members, ADAM10 and ADAM17, are indispensable for embryonic development in mice [1, 2] . Loss of ADAM17 is associated with severe multiorgan dysfunction in humans. Patients with a homozygous mutation in ADAM17 presented with severe diarrhea, skin rash, and recurrent sepsis [3] [4] [5] .

ADAM17 was originally identified as the TNF-alpha releasing enzyme [6, 7] . Today, ADAM17 is known to be involved in the shedding of an increasing number of cell surface proteins including the EGFR ligands TGF-α and amphiregulin (AREG), TNF receptor 1, and L-selectin. Very diverse biological processes are thus regulated by a single protease.

ADAM10 is the major sheddase of cell adhesion molecules including neuronal (N)cadherin [8] , epithelial (E)-cadherin [9] , and vascular-endothelial (VE)-cadherin [10] , but also releases the EGFR ligands betacellulin (BTC) and EGF [11] and the low affinity IgE receptor CD23 [12] . Moreover, the protease mediates the non-amyloidogenic α-secretase cleavage of the Alzheimer's precursor protein. Dysregulated ADAM10 activity is assumed to play a central role in diverse pathologies including Alzheimer's disease, allergic responses, and cancer development [13, 14] .

The bewilderingly wide spectrum of potential substrates on the one hand is matched by the complexity of cellular processes that fine-tune the individual shedding events on the other. The post-translational regulation of ADAM10 and ADAM17 sheddase activity is multifaceted. For ADAM17, inactive rhomboid proteins, iRhom1 and iRhom2, are assumed to be key regulators of maturation, protease function and substrate selectivity [15] [16] [17] . Tetraspanins play an important role for ADAM10 subcellular localization and substrate interaction [18, 19] . Moreover, sheddase activity is modulated by changing interaction partners as well as subcellular compartmentalization [20] .

A remarkably broad and heterogeneous spectrum of stimuli has been found to activate the enzymes [21] [22] [23] [24] , whereupon substrate cleavage occurs at sites located very close to the cell membrane surface.

Functional upregulation of ADAM10 is generally observed in association with cytosolic Ca 2+ elevation-as elicitable by treatment of cells with Ca 2+ ionophores, purinergic receptor agonists, or membrane-perturbating agents [23, 25, 26] . ADAM17 sheddase activity is amplified by more diverse signaling pathways including activation of protein kinase C (PKC) and tyrosine kinases such as VEGFR2 or EGFR [27] .

The main thrust of research into the control of sheddase activation has been conducted on these two proteases. They have targeted dissection of events underlying the trafficking of the proteases to the cell surface, and of regulatory roles assignable to the extracellular domains of the proteases [28, 29] . The present review introduces a novel aspect into the discussion. We summarize current knowledge regarding the significance of PS externalization on proteolytic activity of ADAM10 and ADAM17. Arguments are presented to support the concept that scramblase-mediated shuffling of phospholipids is a key step leading to ADAM10 and ADAM17 activation [30] [31] [32] [33] [34] [35] . The potential functional consequences of these interactions are discussed and future challenges to be met in field are outlined.

The multifaceted role of the cell membrane in the regulation of shedding has been an emerging theme in recent years [26, 36] . Cell membrane fluidity appears to directly promote substrate-protease interaction. Fluidity is affected by content of cholesterol and unsaturated free fatty acids (FFA). Membrane cholesterol depletion led to increased sheddase activity, as did the enhancement of lateral protein mobility evoked through incorporation of unsaturated FFA [37] .

Organization of membrane nanostructure is a second major issue. Nanodomains rich in cholesterol and sphingolipids are thought to form platforms for substrate-protease interaction in the plasma membrane. Depletion of cholesterol or sphingomyelin enhances shedding of several ADAM substrates. Application of sphingomyelinase leads to formation of ceramide-enriched nanodomains. This resulted in increased ADAM17-mediated release of substrates in different cells [24] .

Increasing evidence indicates that assembly in multiprotein complexes modulates ADAM locations and thus discriminates substrate specificity as well as timing of sheddase activation. Vesicular compartments and intracellular organelles work as structural scaffolds to coordinate specificity and temporal activity of functional hubs in cell signaling and enzymatic function [20] .

A germane property of common ADAM stimuli is the breakdown of phospholipid asymmetry. The non-random distribution of different lipid species in the lipid bilayer is a common feature of all eukaryotic membranes. Phosphatidylserine (PS) is exclusively located in the inner leaflet while phosphatidylcholine (PC) and glycolipids are mainly located in the outer leaflet of the membrane. This asymmetry is maintained by P4-type ATPases (flippases), which transfer the amino phospholipids PS and phosphatidylethanolamine (PE) to the cytoplasmic membrane leaflet [38, 39] .

Irreversible PS externalization occurring upon ATP depletion is a key signal for apoptotic cell clearance. Massive PS externalization in activated platelets triggers blood and platelet coagulation [40] .

Less well known is the fact that breakdown of membrane asymmetry also occurs as a transient event in many physiological situations. Among others, surface PS exposure is involved in myoblast and osteoclast fusion and is critical for neuronal regeneration [40] . 3 of 13 PS is externalized through the activation of scramblases, proteins that non-specifically and bidirectionally translocate phospholipids between the outer and inner leaflets of the plasma membrane. The existence of scramblases was postulated decades ago, but their molecular identity eluded definition until recently. Diverse transmembrane proteins have been implicated in lipid scrambling. Members of the TMEM16 family are by far the best characterized [41, 42] .

There are 10 human TMEM16/Anoctamin (ANO) proteins. Although structurally related, TMEM16A/ANO1 and TMEM16B/ANO2 function as Ca 2+ -activated chloride channels and lack scramblase activity. Mammalian TMEM16C/ANO3, D/ANO4, E/ANO5, G/ANO7, and K/ANO10 are primarily assigned scramblase activity, while TMEM16F/ANO6 and TMEM16J/ANO9 apparently fulfil dual functions as cationic channels and scramblases [41, 43, 44] . The function of TMEM16H/ANO8 has not yet been elucidated. ANOprovoked breakdown of cell membrane phospholipid asymmetry can trigger a plethora of cellular responses such as blood coagulation [45, 46] , microparticle release [47] , membrane repair [48] , cell-cell fusion [49] [50] [51] [52] , and viral infection [40, 53, 54] . Malfunctions in TMEM16/ANO proteins have been implicated in human diseases, including asthma, cancer, bleeding disorders, muscular dystrophy, arthritis, epilepsy, dystonia, and ataxia [55] [56] [57] [58] .

Scramblase activity at the plasma membrane was also attributed to members of the Xkr family which comprises nine family members in humans. Xkr8 was shown to facilitate PS exposure in apoptotic cells by a mechanism that involves cleavage by caspases or activation via phosphorylation near the caspase recognition site [59, 60] . Apoptotic Xkr8-deficient cells do not expose PS. After transfection with Xkr4, Xkr8, or Xkr9, they responded to apoptotic stimuli with PS exposure at the cell surface [59] . However, the question whether these proteins act as bona fide lipid scramblases is still a matter of debate since studies with purified proteins reconstituted into synthetic vesicles have yielded contradicting results with XKR9 [61] and are not available for XKR4 and XKR8.

There is a third family of phospholipid-translocating proteins, designated phospholipid scramblases (PLSCR). Four human members of this family have been identified hPLSCR1-4 [62] . hPLSCR1 and hPLSCR3, the most extensively studied proteins in this family, are reported to have crucial roles in apoptosis. Recombinant purified hPLSCR1, hPLSCR3 and hPLSCR4 showed scrambling activity in vitro when reconstituted in proteoliposomes [63] , but the true in vivo role of hPLSCRs in PS exposure still remains a matter of debate [40, 64, 65] .

In addition, some other transmembrane proteins have recently been implicated in lipid scrambling such as few G protein-coupled receptors, the autophagy protein Atg9, and the ER protein complex TMEM41B/VMP1 [66] [67] [68] .

Scott syndrome is a rare bleeding disorder caused by the incapacity of blood cells to expose PS in response to intracellular Ca 2+ elevation. The defect is due to a missense mutation in the calcium-dependent PS scramblase ANO6 [45, 69] . The link between the function of sheddases and scramblases was initially uncovered through experiments with lymphocytes from Scott syndrome patients. Calcium influx provoked rapid PS exposure and loss of the ADAM17 substrate L-selectin in normal B-cells, but Scott lymphocytes responded neither with PS exposure nor with substrate shedding. Expression of caspase-dependent scramblases is unaltered in Scott lymphocytes, so the decisive experiment was performed to examine whether apoptosis induction would provoke normal PS-externalization and shedding of the ADAM17 substrate. This turned out to be the case, and the possible mechanism underlying ADAM17 activation by PS was investigated [35] . If PS directly interacted with the protease, its soluble head group ortho-phosphorylserine (OPS) would possibly act as a competitive inhibitor. Indeed, ADAM17-dependent substrate shedding was found to be reduced in the presence of OPS in several cell models.

This prompted a search for a PS interaction motif in the ectodomain of the protein. Commencing at the membrane surface, the ectodomain comprises a stalk region, a membrane-proximal domain (MPD), a disintegrin-like domain, and the catalytic domain with resolved crystal structure [70, 71] (Figure 1 ). The stalk region of ADAM17 contains a unique evolutionally conserved sequence called CANDIS (Conserved Adam seventeeN Dynamic Interaction Sequence), which forms an amphipathic helix that can interact with the cell membrane [72] .

would possibly act as a competitive inhibitor. Indeed, ADAM17-dependent substra shedding was found to be reduced in the presence of OPS in several cell models.

This prompted a search for a PS interaction motif in the ectodomain of the protei Commencing at the membrane surface, the ectodomain comprises a stalk region, a mem brane-proximal domain (MPD), a disintegrin-like domain, and the catalytic domain wi resolved crystal structure [70, 71] (Figure 1 ). The stalk region of ADAM17 contains unique evolutionally conserved sequence called CANDIS (Conserved Adam seventee Dynamic Interaction Sequence), which forms an amphipathic helix that can interact wi the cell membrane [72] .

The MPD represented a likely candidate for interaction with PS because of its pro imity to the membrane surface. To test for this possibility, recombinant MPD was pr duced and found to bind to PS but not to PC liposomes. NMR-spectroscopy localized th PS interaction site to a cluster of basic amino acids, R625/K626/K628. Mutation of the amino acids to glycines abolished PS binding capacity. When the corresponding ADAM mutant was transfected into ADAM10/ADAM17-double deficient cells, it was no long able to cleave its physiological substrate TGF-α. However, the cells did express ADAM on their surface and the mutated protease was still capable of cleaving a soluble peptid substrate in the culture medium. A key finding was thus made that abrogation of PS bin ing selectively affected the release of cell membrane-bound substrates but not the bon fide enzymatic activity of the protease (Figure 1 ). The MPD represented a likely candidate for interaction with PS because of its proximity to the membrane surface. To test for this possibility, recombinant MPD was produced and found to bind to PS but not to PC liposomes. NMR-spectroscopy localized the PS interaction site to a cluster of basic amino acids, R625/K626/K628. Mutation of these amino acids to glycines abolished PS binding capacity. When the corresponding ADAM17 mutant was transfected into ADAM10/ADAM17-double deficient cells, it was no longer able to cleave its physiological substrate TGF-α. However, the cells did express ADAM17 on their surface and the mutated protease was still capable of cleaving a soluble peptide substrate in the culture medium. A key finding was thus made that abrogation of PS binding selectively affected the release of cell membrane-bound substrates but not the bona fide enzymatic activity of the protease (Figure 1 ).

The relevance of these findings was confirmed in vivo. Mutagenesis of the three amino acids constituting the PS-binding motif led to embryonic lethality in mice [32] . Primary hepatocytes and fibroblasts were found to express the mutant protease on the cell surface. However, release of ADAM17 substrates was completely abolished. The results directly supported the concept of transiently externalized PS as the essential trigger of ADAM17 sheddase activity in vivo.

Further studies bore out the contention that ANO6 is a key regulator of ADAM17 function [30] . Overexpression of ANO6 in HEK293T cells led to increased Ca 2+ -mediated PS exposure that was accompanied by enhanced release of ADAM17 substrates. Transfection of cells with a constitutively active ANO6 mutant led to spontaneous PS exposure and to enhanced release of ADAM17 substrates in the entire absence of any stimuli. Inhibitor experiments indicated that ANO6-mediated enhancement of substrate cleavage simultaneously broadened the spectrum of participating metalloproteinases. Complementary experiments showed that siRNA-mediated downregulation of ANO6 in human umbilical vein endothelial cells decreased ionophore-mediated release of TNFR1.

The question arose whether the homologous protease ADAM10 would similarly be subject to regulation by ANO6 and PS exposure.

Our results pointed to such a scenario [31] . Overexpression of ANO6 led to increased PS externalization and substrate release. Transfection with a constitutively active form of ANO6 resulted in maximum sheddase activity in the absence of any stimulus. Calciumdependent ADAM10 activation could not be induced in lymphocytes of patients with Scott syndrome harboring a missense mutation in ANO6. In principle analogy with ADAM17, inhibition experiments with soluble OPS indicated that triggering of proteolytic activity involved a direct interaction of surface-exposed PS with the protein. ADAM10 has basically a similar modular structure as ADAM17. The X-ray crystal structure of the ADAM10 ectodomain has been elucidated by Seegar et al [73] . It was found that the enzyme active site is occluded by a short peptide loop located at the commencement of the stalk region (residues 647-655). We became aware that a putative PS binding site similar to the cationic motif identified in ADAM17 follows immediately after this inhibitory loop (residues 657/659/660) within the ADAM10 stalk region. Alteration of this motif abrogated sheddase activation by externalized PS [31] . A simple model evolved in which surfaceexposed PS attracts and draws this peptide sequence down to the membrane surface. As a result, the enzyme-inhibiting loop will be drawn out of the catalytic site which can then access its intended substrate [31] .

Transient PS exposure is integral to a multitude of activation events in cells of the immune system, although the relevance thereof remains unclear in many instances. Such is the case with activated neutrophils [74] . In mast cells, transient exposure and cell degranulation are co-induced by IgE receptor stimulation [75] . Transient PS externalization has also been described in T cells. Elliott et al. identified a role for PS distribution changes in signal transduction, rapidly modulating the activities of several membrane proteins including the P2X 7 cation channel [76] . P2X 7 -stimulated transient PS externalization induced shedding of the homing receptor L-selectin in T cells. In macrophages, ANO6 could be identified as a responsible scramblase and essential component of innate immunity downstream of P2X 7 [77] . A new link was recently uncovered between an immunological axis and the function of sheddases. CD137 is a member of the TNFR family that functions as costimulatory molecule, promoting proliferation and survival of activated T cells. A soluble form of CD137 (sCD137), hitherto considered to represent a splice variant of the membrane-anchored molecule, circulates and is elevated in plasma of patients with rheumatoid arthritis and diverse malignancies [78] [79] [80] . A directed search led to the finding that ADAM10 is centrally involved in the generation of sCD137 [33] . Release of sCD137 was markedly suppressed when ADAM10 sheddase function was inhibited by either conventional inhibitors or through the presence of soluble phosphorylserine. Overexpression of ANO6 increased stimulated shedding, and hyperactive ANO6 led to maximal constitutive shedding of CD137. sCD137 was functionally active and augmented T cell proliferation ( Figure 2 ). The collective findings potentially impact current immunotherapeutic approaches that are targeting CD137 in a variety of diseases. matoid arthritis and diverse malignancies [78] [79] [80] . A directed search led to the finding that 238 ADAM10 is centrally involved in the generation of sCD137 [33] . Release of sCD137 was 239 markedly suppressed when ADAM10 sheddase function was inhibited by either conven-240 tional inhibitors or through the presence of soluble phosphorylserine. Overexpression of 241 ANO6 increased stimulated shedding, and hyperactive ANO6 led to maximal constitutive 242 shedding of CD137. sCD137 was functionally active and augmented T cell proliferation 243 (Figure 2 ). The collective findings potentially impact current immunotherapeutic ap-244 proaches that are targeting CD137 in a variety of diseases. Whether sCD137 could fulfill additional functions, e.g., activation of antigen-presenting cells 250 (APCs) or act as decoy is still not clear. 251 

TMEM16 proteins are associated with diverse malignancies. Overexpression corre-253 lates with poor prognosis in breast, head and neck, and pancreas cancer [39, 81] . Inhibition 254 of TMEM16A/ANO1 function reportedly suppresses cancer cell proliferation and migra-255 tion [82, 83] . TMEM16D/ANO4 has been associated with breast cancer [84, 85] . 256 TMEM16G/ANO7 is upregulated in prostate cancer [86] . TMEM16J/ANO9 was linked to 257 pancreatic and colorectal cancer [87, 88] . In pancreatic cancer it supposedly promotes tu-258 morigenesis via modulation of EGFR signaling. This equates with a direct link to ADAM10 259 and ADAM17, which are the major sheddases of EGFR ligands. In an immediate context, 260 both ADAMs play a profound role in many types of cancers [89, 90] . Recent results from 261 our working group indicate a direct link between ANO4 and ANO9 scramblase activity 262 and ADAM function [34] . Overexpression of ANO4 and ANO9 led to increased release of 263 ADAM10 and ADAM17 substrates, such as betacellulin, TGF-α, and AREG, upon iono-264 phore stimulation in HEK cells. Increased PS exposure was observed under constitutive 265 as well as under stimulated conditions. The direct link between scramblase activity and 266 ADAM activity emerged in competition experiments with the soluble PS headgroup phos-267 phorylserine. Overexpression of ANO4 or ANO9 in human cervical cancer cells (HeLa) 268 enhanced constitutive shedding of the growth factor AREG and increased cell prolifera-269 tion. These data indicate that ANO4 and ANO9, by virtue of their scramblase activity, 270 may play a role as important regulators of ADAM-dependent tumor cell functions. Un-271 covering the detailed connections between TMEM proteins and ADAMs in cancer will 272 become a rewarding field of cancer research in the foreseeable future. 273 Figure 2 . Transient exposure of PS plays an important role in the immune system. One example is the release of the TNFR family member CD137 via ADAM10 (or ADAM17). Soluble CD137 (sCD137) can bind to its ligand CD137L expressed on activated T cells and activate cell signaling. Whether sCD137 could fulfill additional functions, e.g., activation of antigen-presenting cells (APCs) or act as decoy is still not clear.

TMEM16 proteins are associated with diverse malignancies. Overexpression correlates with poor prognosis in breast, head and neck, and pancreas cancer [39, 81] . Inhibition of TMEM16A/ANO1 function reportedly suppresses cancer cell proliferation and migration [82, 83] . TMEM16D/ANO4 has been associated with breast cancer [84, 85] . TMEM16G/ANO7 is upregulated in prostate cancer [86] . TMEM16J/ANO9 was linked to pancreatic and colorectal cancer [87, 88] . In pancreatic cancer it supposedly promotes tumorigenesis via modulation of EGFR signaling. This equates with a direct link to ADAM10 and ADAM17, which are the major sheddases of EGFR ligands. In an immediate context, both ADAMs play a profound role in many types of cancers [89, 90] . Recent results from our working group indicate a direct link between ANO4 and ANO9 scramblase activity and ADAM function [34] . Overexpression of ANO4 and ANO9 led to increased release of ADAM10 and ADAM17 substrates, such as betacellulin, TGF-α, and AREG, upon ionophore stimulation in HEK cells. Increased PS exposure was observed under constitutive as well as under stimulated conditions. The direct link between scramblase activity and ADAM activity emerged in competition experiments with the soluble PS headgroup phosphorylserine. Overexpression of ANO4 or ANO9 in human cervical cancer cells (HeLa) enhanced constitutive shedding of the growth factor AREG and increased cell proliferation. These data indicate that ANO4 and ANO9, by virtue of their scramblase activity, may play a role as important regulators of ADAM-dependent tumor cell functions. Uncovering the detailed connections between TMEM proteins and ADAMs in cancer will become a rewarding field of cancer research in the foreseeable future.

Another interesting aspect of the role of ADAMs and scramblases in cancer concerns the role of extracellular vesicles (EVs). Released exosomes are present in body fluids including blood or bronchoalveolar fluid, and this release is increased in many pathologies ranging from oncogenesis to inflammation [91, 92] . Cancer cell released exosomes play an important role in promoting progression of cancers by increasing their invasive potential [93] . They are carried through the blood and lymph circulation and affect the development of the primary tumor as well as distant metastasis through the transfer of RNA and proteins [94] . Externalization of PS and PE alters lipid packing in the membrane and influences the membrane curvature [95] . An important consequence is the release of extracellular vesicles as intercellular messengers. A direct connection of Anoctamins with vesicle and exosome release has been described [81, 95] . In particular, a central role for the release of vesicles has been reported for ANO6 [47, 96, 97] and ANO1 [98] . A similar function has been suggested for ANO7 in the context of prostate cancer [99] that might also apply for other Anoctamin family members. In this context, it is of distinct interest that both ADAM10 and ADAM17 are reportedly present in exosomes [20] . It has been shown that exosomal ADAM10 and ADAM17 retain their biological activity and enhance substrate release in target cells. Addition of exosomes to cells expressing the ADAM17 substrates TGF-α and amphiregulin led to enhanced shedding [100] . Notably, contribution of exosomal ADAM10 activity could also be shown for shedding of the ADAM10 substrates CD44 and L1 [101] [102] [103] . Increased ANO scramblase activity could thus enhance ADAM activity and the release of, e.g., tumor growth factors on the same cell. In addition, ANO scramblase activity could increase the release of ADAM-containing vesicles that could further promote tumor growth in distant target cells.

The presence of PS in the target membrane promotes fusion of many enveloped viruses with host cells [39, 104, 105] . HIV-1 entry into host cells starts with interactions between the viral envelope glycoprotein (Env) and cellular CD4 receptors and co-receptors. Formation of the pre-fusion receptor/co-receptor complexes triggers non-apoptotic cell surface exposure of PS. This event involves activation of the lipid scramblase TMEM16F/ANO6 and depends on Ca 2+ signaling. Externalized PS promotes Env-mediated membrane fusion and HIV-1 infection. Blockade of externalized PS or suppression of TMEM16F resulted in the inhibition of Env-mediated fusion and infection [53] . Promotion of membrane fusion by surfaceexposed PS seems to be relevant for the entry of many other viruses including vesicular stomatitis virus (VSV) or alpha-herpesvirus into the cell [106, 107] .

Further to allowing viral entry, PS externalization may play a general downstream role because viral replication necessarily involves cell activation events that will involve Ca 2+ influx. Then, activation of scramblases and sheddases cannot but follow. Perhaps these recent recognitions will provide the speculation with further impetus that targeting exposed anionic phospholipids might protect against lethal virus infections in vivo [105] .

The spike protein of SARS-CoV-2 can also activate TMEM16F/ANO6 and thus induce syncytia formation [50] , a finding consistent with the previously proposed role of PS exposure in physiologic cell fusion events [40] . Moreover, it has been speculated that PS exposure may be an important mechanism related to ADAM17-mediated ACE2, TNF-alpha, EGFR and IL-6R shedding that might contribute to the pathophysiology of COVID-19 inflammation and coagulation abnormalities [108] . However, the possible relevance for the disease is not clear.

PS externalization could promote virus infection in an additional way, namely by activating ADAM sheddase function. The importance of ADAM activity for viral infections was recently demonstrated for human papillomavirus (HPV) [109] . HPVs are small DNA viruses that infect epithelial cells. After HPV binding to cell surface receptors, a cascade of molecular interactions mediates viral internalization. Metalloproteases of unknown identity appeared to be involved in these processes [110] , and we recently identified ADAM17 as the prime candidate [109] . It was found that shedding of growth factors by ADAM17 triggered the extracellular signal-regulated kinases (ERK1/2) pathway, which then led to formation of the endocytic entry platform for the virus (Figure 3) . In subsequent studies, the tetraspanin CD9 was identified as another regulator of ADAM17 activity and HPV infection [111] .

An interesting link to ADAM10 comes from the field of bacterial defense. ADAM10 is a high-affinity receptor for cytotoxic Staphylococcus aureus alpha-toxin [112] . The protease itself is subject to cleavage and removal from the membrane surface by other sheddases [113] . This must be expected to render the respective cells less susceptible to the action of alphatoxin, one of the most important pathogenicity factors of Staphylococcus aureus [114] . Intriguingly, Lizak and Yarovinsky (2012) have reported that IFNα-mediated protection from alpha-toxin is dependent on induction of PLSCR1 [115] . If increased expression of PLSCR1 would lead to enhanced PS exposure, the activation of transmembrane metalloproteases might reduce the surface amounts of ADAM10 and limit the cytotoxic effects of alpha-toxin.

aureus [114] . Intriguingly, Lizak and Yarovinsky (2012) have reported that IFNα-mediated 337 protection from alpha-toxin is dependent on induction of PLSCR1 [115] . If increased ex-338 pression of PLSCR1 would lead to enhanced PS exposure, the activation of transmem-339 brane metalloproteases might reduce the surface amounts of ADAM10 and limit the cyto-340 toxic effects of alpha-toxin. 341 It is evident that we are witnessing just the beginning of an exciting field of research 342 into the interwoven roles of scramblases and sheddases in the context of viral and bacterial 343 infections. 

Externalization of PS effected by scramblases is envisaged to exert a key regulatory 352 function in controlling substrate cleavage by ADAM10 and ADAM17. Major challenges 353 arise for future research. There is still little reliable data that indicate whether proposed 354 scramblase proteins indeed function as a scramblase or whether other molecules are nec-355 essary. This could only be examined by appropriate in vitro reconstitution assays in syn-356 thetic proteoliposomes. In addition, knockout and gain of function mouse models could 357 help to further understand the in vivo relevance and the potential compensation mecha-358 nisms. It is obvious that several proteins must be involved in such a central element of life 359 as the regulation cell membrane asymmetry. It is also clear that ADAM10 and ADAM17 360 will not be the only proteins whose function is regulated by scramblases. Our data indi-361 cate that ANO6-mediated enhancement of substrate cleavage simultaneously broadened 362 the spectrum of participating metalloproteinases far beyond ADAM10 and ADAM17 [30] . 363 In accordance with the literature, cleavage of TGF-alpha provoked by ionophore in nor-364 mal cells is affected predominantly by ADAM17 and inhibitable with ADAM17 inhibitors. 365 It is evident that we are witnessing just the beginning of an exciting field of research into the interwoven roles of scramblases and sheddases in the context of viral and bacterial infections.

Externalization of PS effected by scramblases is envisaged to exert a key regulatory function in controlling substrate cleavage by ADAM10 and ADAM17. Major challenges arise for future research. There is still little reliable data that indicate whether proposed scramblase proteins indeed function as a scramblase or whether other molecules are necessary. This could only be examined by appropriate in vitro reconstitution assays in synthetic proteoliposomes. In addition, knockout and gain of function mouse models could help to further understand the in vivo relevance and the potential compensation mechanisms. It is obvious that several proteins must be involved in such a central element of life as the regulation cell membrane asymmetry. It is also clear that ADAM10 and ADAM17 will not be the only proteins whose function is regulated by scramblases. Our data indicate that ANO6-mediated enhancement of substrate cleavage simultaneously broadened the spectrum of participating metalloproteinases far beyond ADAM10 and ADAM17 [30] . In accordance with the literature, cleavage of TGF-alpha provoked by ionophore in normal cells is affected predominantly by ADAM17 and inhibitable with ADAM17 inhibitors. In cells overexpressing ANO6, however, the substrate release could not be blocked anymore with ADAM17 inhibitors but only with broad-spectrum metalloprotease inhibitors, indicating that further metalloproteases participated in the cleavage of TGF-alpha [30] . Recently, we obtained similar results upon ANO4 and ANO9 overexpression [34] . Could other membrane-anchored proteases or proteins operating at the cell surface underlie similar regulatory principles? These and many other intriguing questions await resolution.

The scramblase-ADAM connection could also be important under pathologic conditions. The proteases promote several inflammatory as well as tumorigenic pathways [90, [116] [117] [118] .

Much less is known about the significance of the scramblases in health and disease, but there are indications that there may be a causal link to protease activity. To target scramblase proteins and treat scramblase-related diseases, it is critical to have a comprehensive understanding of these proteins and their function at the molecular level. Elucidation of the possible links between scramblase activity and protease/protein function represent an exciting future challenge for research in cell membrane biology.

The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for α-secretase activity in fibroblasts

An essential role for ectodomain shedding in mammalian development

Inflammatory skin and bowel disease linked to ADAM17 deletion

Loss of ADAM17 is associated with severe multiorgan dysfunction

Cytokine secretion and NK cell activity in human ADAM17 deficiency

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling

ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation

ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

Signalling scissors in the tumour microenvironment

ADAM10 as a therapeutic target for brain diseases: From developmental disorders to Alzheimer's disease

The Role of iRhom2 in Metabolic and Cardiovascular-Related Disorders. Front. Cardiovasc

Status update on iRhom and ADAM17: It's still complicated

Substrateselective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains

Regulation of ADAM10 by the TspanC8 Family of Tetraspanins and Their Therapeutic Potential

Regulation of the trafficking and the function of the metalloprotease ADAM10 by tetraspanins

Adam10 site-dependent biology: Keeping control of a pervasive protease

Melittin modulates keratinocyte function through P2 receptor-dependent ADAM activation

Shedding light on ADAM metalloproteinases

Pore-forming bacterial toxins and antimicrobial peptides as modulators of ADAM function

Extracellular sphingomyelinase activity impairs TNF-α-induced endothelial cell death via ADAM17 activation and TNF receptor 1 shedding

Roles of extracellular nucleotides and P2 receptors in ectodomain shedding

The plasma membrane: Penultimate regulator of ADAM sheddase function

The Enzyme That Does It All

The cytoplasmic domain of a disintegrin and metalloproteinase 10 (ADAM10) regulates its constitutive activity but is dispensable for stimulated ADAM10-dependent shedding

Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids

Anoctamin-6 regulates ADAM sheddase function

ADAM10 sheddase activation is controlled by cell membrane asymmetry

Mutagenesis of the ADAM17-phosphatidylserine-binding motif leads to embryonic lethality in mice

Role of adam10 and ADAM17 in regulating cd137 function

Influence of Anoctamin-4 and -9 on ADAM10 and ADAM17 Sheddase Function

Phosphatidylserine exposure is required for ADAM17 sheddase function

How membrane asymmetry regulates ADAM17 sheddase function

Unsaturated fatty acids drive disintegrin and metalloproteinase (ADAM)-dependent cell adhesion, proliferation, and migration by modulating membrane fluidity

Role of Flippases, Scramblases and Transfer Proteins in Phosphatidylserine Subcellular Distribution

Phosphatidylserine exposure in living cells

Getting to the outer leaflet: Physiology of phosphatidylserine exposure at the plasma membrane

The Groovy TMEM16 Family: Molecular Mechanisms of Lipid Scrambling and Ion Conduction

Transport Pathways That Contribute to the Cellular Distribution of Phosphatidylserine. Front

Known structures and unknown mechanisms of TMEM16 scramblases and channels

Calcium-dependent phospholipid scramblase activity of TMEM 16 protein family members

Calcium-dependent phospholipid scrambling by TMEM16F

TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation

TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets

Critical Role of Lipid Scramblase TMEM16F in Phosphatidylserine Exposure and Repair of Plasma Membrane after Pore Formation

Anoctamin 5/TMEM16E facilitates muscle precursor cell fusion

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy

TMEM16F phospholipid scramblase mediates trophoblast fusion and placental development

Fusion Stage of HIV-1 Entry Depends on Virus-Induced Cell Surface Exposure of Phosphatidylserine

Role of Transmembrane Protein 16F in the Incorporation of Phosphatidylserine Into Budding Ebola Virus Virions

Physiological roles and diseases of tmem16/anoctamin proteins: Are they all chloride channels? Proc

Structure and function of tmem16 proteins (anoctamins)

Cellular functions of TMEM16/anoctamin

The multifaceted role of TMEM16A in cancer

Exposure of phosphatidylserine by Xkrelated protein family members during apoptosis

Phosphorylation-mediated activation of mouse Xkr8 scramblase for phosphatidylserine exposure

Cryo-EM structures of the caspase-activated protein XKR9 involved in apoptotic lipid scrambling

Roles and regulation of phospholipid scramblases

Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids

The role of human phospholipid scramblases in apoptosis: An overview

Phospholipid scramblases: An overview

Phospholipid Scrambling by G Protein-Coupled Receptors

Structure, lipid scrambling activity and role in autophagosome formation of ATG9A

TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis

Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome

Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme

Molecular insights into the multilayered regulation of ADAM17: The role of the extracellular region

Extracellular Juxtamembrane Segment of ADAM17 Interacts with Membranes and Is Essential for Its Shedding Activity

Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10

Phospholipid Flip-Flop and Phospholipid Scramblase 1 (PLSCR1) Co-localize to Uropod Rafts in Formylated Met-Leu-Phe-stimulated Neutrophils

Immunologic stimulation of mast cells Leads to the reversible exposure of phosphatidylserine in the absence of apoptosis

Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes

Anoctamin 6 mediates effects essential for innate immunity downstream of P2X7 receptors in macrophages

Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia

A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis

Clinical implications of elevated serum soluble CD137 levels in patients with acute coronary syndrome

Contribution of anoctamins to cell survival and cell death

Identification of the novel TMEM16A inhibitor dehydroandrographolide and its anticancer activity on SW620 cells

Role of anoctamins in cancer and apoptosis

Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer

Prediction of functional consequences of missense mutations in ano4 gene

ANO7 is associated with aggressive prostate cancer

ANO9/TMEM16j promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer

Identification and characterization of ANO9 in stage II and III colorectal carcinoma

The metalloprotease ADAM17 in inflammation and cancer

Exosomes in breast cancer-Mechanisms of action and clinical potential

Extracellular Vesicles as Inflammatory Drivers in NAFLD. Front

Exosomes in cancer development, metastasis, and drug resistance: A comprehensive review

Comparative Study of Extracellular Vesicles from the Urine of Healthy Individuals and Prostate Cancer Patients

Anoctamins/TMEM16 Proteins: Chloride Channels Flirting with Lipids and Extracellular Vesicles

TMEM16F activation by Ca 2+ triggers plasma membrane expansion and directs PD-1 trafficking

Chemically induced vesiculation as a platform for studying TMEM16F activity

Calmodulin-dependent activation of the epithelial calcium-dependent chloride channel TMEM16A

The interactome of the prostate-specific protein Anoctamin 7

Stimulated release and functional activity of surface expressed metalloproteinase ADAM17 in exosomes

ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles

Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells

A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44

Enhancement of Enveloped Virus Entry by Phosphatidylserine

Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases

Binding of alphaherpesvirus glycoprotein H to surface α4β1-integrins activates calcium-signaling pathways and induces phosphatidylserine exposure on the plasma membrane

Membrane Recognition by Vesicular Stomatitis Virus Involves Enthalpy-Driven Protein-Lipid Interactions

Phosphatidylserine inside out: A possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19

ADAM17-dependent signaling is required for oncogenic human papillomavirus entry platform assembly

Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections

Tetraspanin CD9 affects HPV16 infection by modulating ADAM17 activity and the ERK signalling pathway

Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury

ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase

Alpha-toxin of Staphylococcus aureus

Phospholipid scramblase 1 mediates type i interferon-induced protection against staphylococcal α-toxin

Targeting ADAM17 Sheddase Activity in Cancer

ADAM10 as a therapeutic target for cancer and inflammation

A disintegrin and metalloproteases" ADAM10 and ADAM17: Novel drug targets with therapeutic potential?